Ann: Results of LCT Parkinsons trial require further analysis, page-100

Ok, thanks. Good to know.

The breakdown of the results is really the crunch here.

Sounds like the l-dopa is an important measure, that maybe should have been employed when the candidates were being screened ! Give themselves a chance at a good result.

Is it difficult to measure the L-Dopa ? Not more surgery I hope !

If LCT can isolate just one patient, and show the dose, the L-Dopa, sex, age, race, subgroup whatever, and show a significantly improved result, more than significant, actually impressive ! then that is enough to attract interest from the big end of town to raise the funds to do it again and get this ship back off the rocks.

Obviously a complex problem curing an incurable disease !

Just 1 from 12 patients. Who did best ? And was it significant ?

.